IgA nephropathy: Difference between revisions
No edit summary |
|||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{DiseaseDisorder infobox | | {{DiseaseDisorder infobox | | ||
Line 17: | Line 18: | ||
{{IgA nephropathy}} | {{IgA nephropathy}} | ||
{{CMG}}; {{ | {{CMG}};{{AE}} {{Rim}}; {{SH}}; {{OO}};{{APM}} | ||
{{SK}} IgA nephritis; IgAN; Berger's disease; synpharyngitic glomerulonephritis, | {{SK}} IgA nephritis; IgAN; Berger's disease; synpharyngitic glomerulonephritis, | ||
Line 46: | Line 47: | ||
== Treatment == | == Treatment == | ||
[[IgA nephropathy medical therapy|Medical Therapy]] | [[IgA nephropathy surgery|Surgery]] | [[IgA nephropathy primary prevention| | [[IgA nephropathy medical therapy|Medical Therapy]] | [[IgA nephropathy surgery|Surgery]] | [[IgA nephropathy primary prevention|Primary Prevention]] | [[IgA nephropathy secondary prevention|Secondary Prevention]] | [[IgA nephropathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[IgA nephropathy future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Latest revision as of 12:49, 20 July 2018
For patient information click here
Template:DiseaseDisorder infobox
IgA nephropathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
IgA nephropathy On the Web |
American Roentgen Ray Society Images of IgA nephropathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]; Dildar Hussain, MBBS [3]; Olufunmilola Olubukola M.D.[4];Ali Poyan Mehr, M.D. [5]
Synonyms and keywords: IgA nephritis; IgAN; Berger's disease; synpharyngitic glomerulonephritis, IgA glomerulonephritis, IgAN - IgA nephropathy, Immunoglobulin A nephropathy
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating IgA nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-ray | CT | MRI | Echocardiography or Ultrasound |Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies